RxDoctor Payments Data

Thomas Mullally, MD

Family Medicine · Croswell, MINPI 1629030879

Payments from drug & device makers

$399in general payments, 2019–2025

Across 22 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Specialty L.p.$161
  • Pfizer$103
  • Amarin Pharma, Inc.$45
  • Xeris Pharmaceuticals, Inc.$23
  • Exact Sciences$19
  • Viatris Specialty LLC$17
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$399 in reported general payments places this provider in the 55th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$134,776
Medicare patients
246
Services billed
2,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin123$155,093
EliquisApixaban114$133,286
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog22$38,583
JanuviaSitagliptin Phosphate18$29,013
XareltoRivaroxaban13$17,227
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,650
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$10,095
OzempicSemaglutide11$9,904
Atorvastatin Calcium586$9,451
Fluticasone-SalmeterolFluticasone Propion/Salmeterol37$8,171
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide334$7,708
Levothyroxine Sodium496$6,050
Losartan Potassium355$5,035
Levemir FlexpenInsulin Detemir14$5,008
Omeprazole282$4,689

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$103$133,286114 claims
GSKTrelegy Ellipta$15$14,65017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Croswell

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →